LOUIS GLECKEL - 09 Jun 2021 Form 4 Insider Report for ProPhase Labs, Inc. (PRPH)

Role
Director
Signature
/s/ Louis Gleckel, MD
Issuer symbol
PRPH
Transactions as of
09 Jun 2021
Transactions value $
$0
Form type
4
Filing time
10 Jun 2021, 16:05:22 UTC
Next filing
05 Jul 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRPH Option (right to buy) Award $0 +100K $0.00 100K 09 Jun 2021 Common Stock 100K $5.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with one-quarter of such stock option vesting on June 30, 2021 and the remaining portion vesting pro rata in equal monthly installments beginning July 31, 2021 and on the last day of each month thereafter, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 9, 2021.